| Casie Leightner, MD | |
|
1101 9th St Se, Sioux Center, IA 51250-2501 | |
| (712) 722-2609 | |
| Not Available |
| Full Name | Casie Leightner |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 5 Years |
| Location | 1101 9th St Se, Sioux Center, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497172456 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sioux Center Health | Sioux center, IA | Hospital |
| Sioux Center Health Royale Meadows | Sioux center, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sioux Center Health | 9032027495 | 29 |
News Archive
There is a need to remove the major ethnic inequalities which still exist in access to cancer services and outcomes, according to the latest edition of Science & Public Affairs.
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
› Verified 9 days ago
| Entity Name | Sioux Center Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669542981 PECOS PAC ID: 9032027495 Enrollment ID: O20040224001315 |
News Archive
There is a need to remove the major ethnic inequalities which still exist in access to cancer services and outcomes, according to the latest edition of Science & Public Affairs.
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
› Verified 9 days ago
| Entity Name | Sioux Center Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1326056755 PECOS PAC ID: 9032027495 Enrollment ID: O20070123000516 |
News Archive
There is a need to remove the major ethnic inequalities which still exist in access to cancer services and outcomes, according to the latest edition of Science & Public Affairs.
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Casie Leightner, MD 1101 9th St Se, Sioux Center, IA 51250-2501 Ph: (712) 722-2609 | Casie Leightner, MD 1101 9th St Se, Sioux Center, IA 51250-2501 Ph: (712) 722-2609 |
News Archive
There is a need to remove the major ethnic inequalities which still exist in access to cancer services and outcomes, according to the latest edition of Science & Public Affairs.
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that combination treatment with milatuzumab, the first humanized anti-CD74 antibody in clinical testing, and veltuzumab, a second-generation humanized anti-CD20 antibody, resulted in therapeutic responses in heavily pretreated and rituximab-refractory non-Hodgkin's lymphoma patients.
A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.
› Verified 9 days ago
Richard Jongewaard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 645 S Main Ave, Sioux Center, IA 51250 Phone: 712-722-2609 Fax: 712-722-8393 | |
Dr. Lyndle Duane Shelby, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1101 9th St Se, Sioux Center, IA 51250 Phone: 712-722-2609 Fax: 712-722-8426 | |
Stacy Lynne Schaap, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 33 4th St Nw, Sioux Center, IA 51250 Phone: 712-722-1700 | |
Lorianne S Andersen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 9th St Se, Sioux Center, IA 51250 Phone: 712-722-2609 Fax: 712-722-4325 | |
Dale Nystrom, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 645 S Main Ave, Sioux Center, IA 51250 Phone: 712-722-2609 Fax: 712-722-8392 | |
Delwyn Lee Lassen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 4th St Nw, Sioux Center, IA 51250 Phone: 712-722-1700 Fax: 712-722-1770 |